CNS Pharmaceuticals (CNSP) Short Interest Ratio & Short Volume $1.21 -0.01 (-0.82%) As of 10:23 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CNS Pharmaceuticals Short Interest DataCNS Pharmaceuticals (CNSP) has a short interest of 629,900 shares, representing 21.57% of the float (the number of shares available for trading by the public). This marks a 94.53% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.3, indicating that it would take 1.3 days of the average trading volume of 675,116 shares to cover all short positions.Current Short Interest629,900 sharesPrevious Short Interest323,800 sharesChange Vs. Previous Month+94.53%Dollar Volume Sold Short$683,441.50Short Interest Ratio1.3 Days to CoverLast Record DateApril 30, 2025Outstanding Shares2,944,000 sharesFloat Size2,920,000 sharesShort Percent of Float21.57%Today's Trading Volume63,704 sharesAverage Trading Volume675,116 sharesToday's Volume Vs. Average9% Short Selling CNS Pharmaceuticals? Sign up to receive the latest short interest report for CNS Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCNSP Short Interest Over TimeCNSP Days to Cover Over TimeCNSP Percentage of Float Shorted Over Time CNS Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025629,900 shares $683,441.50 +94.5%21.6%1.3 $1.09 4/15/2025323,800 shares $309,876.60 -4.4%11.1%0.6 $0.96 3/31/2025338,700 shares $460,632.00 +88.1%11.6%0.5 $1.36 3/15/2025180,100 shares $561,912.00 -32.9%6.2%0.3 $3.12 2/28/2025268,500 shares $652,455.00 +241.6%9.9%0.5 $2.43 2/15/202578,600 shares $550,200.00 -97.8%5.2%0.1 $7.00 1/31/20253,630,000 shares $345,213.00 -19.9%N/A0.2 $0.10 1/15/20254,530,000 shares $498,300.00 +861.6%N/A0.2 $0.11 12/31/2024471,100 shares $56,720.44 -64.8%N/A0 $0.12 12/15/20241,340,000 shares $137,886.00 -35.3%N/A0.1 $0.10 Get the Latest News and Ratings for CNSP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CNS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/30/20242,070,000 shares $231,840.00 +202.9%N/A0.1 $0.11 11/15/2024683,300 shares $71,814.83 -40.1%N/A0 $0.11 10/31/20241,140,000 shares $127,224.00 +2.7%N/A0.1 $0.11 10/15/20241,110,000 shares $137,862.00 +63.5%N/A0.1 $0.12 9/30/2024679,000 shares $88,609.50 +86.2%N/A0.1 $0.13 9/15/2024364,600 shares $54,033.72 +80.1%N/A0.1 $0.15 8/31/2024202,500 shares $31,833.00 +87.7%N/A0 $0.16 8/15/2024107,900 shares $15,213.90 -90.3%N/A0 $0.14 7/31/20241,110,000 shares $351,648.00 +314.3%40.1%0.3 $0.32 7/15/2024267,900 shares $316,122.00 +229.9%9.7%0.2 $1.18 6/30/202481,200 shares $128,296.00 +29.7%5.8%0.1 $1.58 6/15/202462,600 shares $174,654.00 +1,465.0%27.3%0.2 $2.79 5/31/20244,000 shares $43,240.00 -93.6%1.8%0.2 $10.81 5/15/202462,500 shares $12,006.25 +100.3%0.6%0.2 $0.19 4/30/202431,200 shares $6,552.00 +35.1%0.3%0.1 $0.21 4/15/202423,100 shares $5,530.14 -53.8%0.2%0.1 $0.24 3/31/202450,000 shares $18,100.00 -51.8%0.5%0.1 $0.36 3/15/2024103,800 shares $36,983.94 +91.5%1.3%0.3 $0.36 2/29/202454,200 shares $15,067.60 -47.2%0.7%0.1 $0.28 2/15/2024102,600 shares $29,035.80 -87.2%1.3%0.3 $0.28 1/31/2024802,400 shares $198,995.20 +317.1%10.2%2.6 $0.25 1/15/2024192,400 shares $179,894.00 -10.8%3.1%1.6 $0.94 12/31/2023215,700 shares $273,939.00 +298.0%3.5%2.1 $1.27 12/15/202354,200 shares $93,766.00 +30.6%0.9%0.5 $1.73 11/30/202341,500 shares $86,320.00 +75.1%0.8%0.6 $2.08 11/15/202323,700 shares $45,504.00 -50.3%0.5%0.3 $1.92 10/31/202347,700 shares $98,739.00 -36.6%1.2%0.3 $2.07 10/15/202375,200 shares $101,520.00 +22.7%1.8%0.5 $1.35 9/30/202361,300 shares $69,882.00 -8.5%1.5%0.5 $1.14 9/15/202367,000 shares $100,500.00 -45.2%1.6%0.4 $1.50How I profit during chaos… (Ad)This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. In the first quarter of this year, in one of the most volatile markets in history, he used his time-tested strategy to go 12 for 12. That's a 100% win–rate — while the rest of the world panics.Here's where a true "Market Wizard" is looking next. 8/31/2023122,300 shares $209,133.00 +69.6%3.0%0.6 $1.71 8/15/202372,100 shares $123,291.00 -3.1%1.8%0.2 $1.71 7/31/202374,400 shares $168,144.00 +11.4%1.8%0.2 $2.26 7/15/202366,800 shares $142,952.00 -70.0%1.6%0 $2.14 6/30/2023222,600 shares $496,398.00 +7.2%5.5%0.1 $2.23 6/15/2023207,600 shares $448,416.00 -9.4%5.1%0.1 $2.16 5/31/2023229,100 shares $421,544.00 +91.6%5.7%0.1 $1.84 5/15/2023119,600 shares $166,244.00 -44.6%3.0%0 $1.39 4/30/2023215,800 shares $325,858.00 +306.4%10.0%0.1 $1.51 4/15/202353,100 shares $124,785.00 +410.6%3.1%0 $2.35 3/31/202310,400 shares $10,400.00 -57.6%0.6%0 $1.00 3/15/202324,500 shares $30,380.00 +49.4%2.3%0.6 $1.24 2/28/202316,400 shares $30,340.00 +62.4%1.6%0.4 $1.85 2/15/202310,100 shares $17,372.00 +206.1%1.0%0.3 $1.72 1/31/20233,300 shares $7,293.00 +153.9%0.3%0.1 $2.21 1/15/20231,300 shares $3,120.00 -63.9%0.1%0.1 $2.40 12/30/20223,600 shares $8,640.00 -65.4%0.3%0.2 $2.40 12/15/202210,400 shares $26,520.00 -2.8%0.8%0.6 $2.55 11/30/202210,700 shares $32,421.00 -88.5%1.1%0.7 $3.03 11/15/202293,200 shares $17,717.32 +24.4%N/A0.5 $0.19 10/31/202274,900 shares $11,984.00 +21.2%N/A0.4 $0.16 10/15/202261,800 shares $12,656.64 -65.7%N/A0.3 $0.20 9/30/2022180,000 shares $32,220.00 -14.6%N/A0.7 $0.18 9/15/2022210,800 shares $51,856.80 +15.0%N/A0.4 $0.25 8/31/2022183,300 shares $44,798.52 -1.6%N/A0.3 $0.24 8/15/2022186,200 shares $48,207.18 +17.7%N/A0.3 $0.26 7/31/2022158,200 shares $34,756.54 +870.6%N/A0.3 $0.22 7/15/202216,300 shares $4,401.00 -95.0%N/A0 $0.27 6/30/2022325,800 shares $91,224.00 +15.4%N/A0.4 $0.28 6/15/2022282,400 shares $77,010.48 -46.6%N/A0.3 $0.27 5/31/2022528,500 shares $160,241.20 +80.6%N/A0.6 $0.30 5/15/2022292,600 shares $84,854.00 -19.7%N/A0.2 $0.29 4/30/2022364,500 shares $123,201.00 -9.5%N/A0.2 $0.34 4/15/2022402,800 shares $157,092.00 +1,154.8%N/A0.3 $0.39 3/31/202232,100 shares $10,946.10 -89.0%N/A0 $0.34 3/15/2022291,000 shares $93,120.00 -46.3%1.6%0.2 $0.32 2/28/2022541,900 shares $211,341.00 +41.6%3.1%0.4 $0.39 2/15/2022382,700 shares $133,945.00 -69.9%2.2%0.5 $0.35 1/31/20221,270,000 shares $763,270.00 +8.6%7.2%1.7 $0.60 1/15/20221,170,000 shares $895,050.00 +353.7%6.6%1.6 $0.77 12/31/2021257,900 shares $181,148.96 +8.8%1.5%0.4 $0.70 12/15/2021237,000 shares $218,182.20 -21.5%1.4%1.1 $0.92 11/30/2021301,800 shares $338,016.00 +16.1%1.7%1.4 $1.12 11/15/2021260,000 shares $293,800.00 -19.7%1.5%1.3 $1.13 10/29/2021323,900 shares $446,982.00 -10.8%1.9%2.2 $1.38 10/15/2021363,200 shares $533,904.00 -2.6%2.1%2.7 $1.47 9/30/2021373,000 shares $555,770.00 -16.9%2.2%2.1 $1.49 9/15/2021448,700 shares $695,485.00 +6.9%2.6%0.9 $1.55 8/31/2021419,600 shares $713,320.00 0.0%2.6%0.8 $1.70 8/13/2021419,700 shares $700,899.00 -3.9%2.6%0.8 $1.67Trump Exec Order 14179 is wealth “gift” to good Americans? (Ad)Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.If you missed out on a bitcoin fortune, this could be your second chance. A brief “wealth window” is 7/30/2021436,900 shares $751,468.00 -28.0%2.9%0.9 $1.72 7/15/2021607,000 shares $1.09 million +57.5%4.0%1.2 $1.80 6/30/2021385,400 shares $755,384.00 +30.4%2.6%0.8 $1.96 6/15/2021295,600 shares $588,244.00 +1.2%2.0%1.9 $1.99 5/28/2021292,100 shares $540,385.00 -12.7%1.9%1.3 $1.85 5/14/2021334,400 shares $571,824.00 +11.1%2.2%1.2 $1.71 4/30/2021300,900 shares $616,845.00 -4.2%2.0%0.5 $2.05 4/15/2021314,100 shares $669,033.00 -17.0%2.1%0.2 $2.13 3/31/2021378,400 shares $877,888.00 -26.9%2.5%0.2 $2.32 3/15/2021517,400 shares $1.38 million -1.4%3.4%0.2 $2.67 2/26/2021524,900 shares $1.51 million +0.8%3.5%0.2 $2.88 2/12/2021520,600 shares $1.92 million +688.8%3.6%0.2 $3.68 1/29/202166,000 shares $119,460.00 -53.2%0.5%0 $1.81 1/15/2021140,900 shares $264,892.00 +13.7%1.0%0.1 $1.88 12/31/2020123,900 shares $219,303.00 +89.7%0.9%0.1 $1.77 12/15/202065,300 shares $158,679.00 -4.3%0.9%0.1 $2.43 11/30/202068,200 shares $163,680.00 -15.0%1.0%1.4 $2.40 11/15/202080,200 shares $170,024.00 +6.5%1.2%1.1 $2.12 10/30/202075,300 shares $134,787.00 -1.3%1.2%0.8 $1.79 10/15/202076,300 shares $144,970.00 -10.7%1.2%0.8 $1.90 9/30/202085,400 shares $150,304.00 -5.6%1.3%0.8 $1.76 9/15/202090,500 shares $177,380.00 -25.6%1.4%0.9 $1.96 8/31/2020121,700 shares $261,655.00 +32.4%1.9%0.9 $2.15 8/14/202091,900 shares $162,663.00 -9.6%1.4%0.9 $1.77 7/31/2020101,600 shares $188,976.00 +19.0%1.6%1.4 $1.86 7/15/202085,400 shares $146,888.00 -15.1%1.3%1.2 $1.72 6/30/2020100,600 shares $215,284.00 -30.6%1.6%0.7 $2.14 6/15/2020144,900 shares $357,903.00 +45.6%2.2%1 $2.47 5/29/202099,500 shares $238,800.00 +22.4%1.5%0.8 $2.40 CNSP Short Interest - Frequently Asked Questions What is CNS Pharmaceuticals' current short interest? Short interest is the volume of CNS Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 629,900 shares of CNSP short. 21.57% of CNS Pharmaceuticals' shares are currently sold short. Learn More on CNS Pharmaceuticals' current short interest. What is a good short interest ratio for CNS Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CNSP shares currently have a short interest ratio of 1.0. Learn More on CNS Pharmaceuticals's short interest ratio. What is a good short interest percentage for CNS Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 21.57% of CNS Pharmaceuticals' floating shares are currently sold short. Is CNS Pharmaceuticals' short interest increasing or decreasing? CNS Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 629,900 shares, an increase of 94.5% from the previous total of 323,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is CNS Pharmaceuticals' float size? CNS Pharmaceuticals currently has issued a total of 2,944,000 shares. Some of CNS Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CNS Pharmaceuticals currently has a public float of 2,920,000 shares. How does CNS Pharmaceuticals' short interest compare to its competitors? 21.57% of CNS Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CNS Pharmaceuticals: GeoVax Labs, Inc. (5.89%), Equillium, Inc. (0.81%), Edesa Biotech, Inc. (0.68%), MEI Pharma, Inc. (0.03%), ProPhase Labs, Inc. (1.09%), 23andMe Holding Co. (11.90%), Relmada Therapeutics, Inc. (6.12%), Trinity Biotech plc (0.92%), Synlogic, Inc. (0.44%), Eterna Therapeutics Inc. (0.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short CNS Pharmaceuticals stock? Short selling CNSP is an investing strategy that aims to generate trading profit from CNS Pharmaceuticals as its price is falling. CNSP shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CNS Pharmaceuticals? A short squeeze for CNS Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CNSP, which in turn drives the price of the stock up even further. How often is CNS Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNSP, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies GeoVax Labs Short Interest Data Equillium Short Interest Data Edesa Biotech Short Interest Data MEI Pharma Short Interest Data ProPhase Labs Short Interest Data 23andMe Short Interest Data Relmada Therapeutics Short Interest Data Trinity Biotech Short Interest Data Synlogic Short Interest Data Eterna Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CNSP) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CNS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
